期刊文献+

清胃理肠胶囊对实验性大鼠溃疡性结肠炎作用机制的研究 被引量:3

Study of the Mechanism of Qingweilichang Capsule in Rats with Experimental Ulcerative Colitis (UC)
暂未订购
导出
摘要 目的观察清胃理肠胶囊对溃疡性结肠炎大鼠结肠病理变化和T淋巴细胞亚群的影响。方法用二硝基氯苯-乙酸复合法制作溃疡性结肠炎大鼠模型,灌胃给药20d后,肉眼及光镜下观察结肠病理变化,流式细胞仪检测外周血CD4+、CD8+百分率,并计算CD4+/CD8+。结果造模后大鼠结肠肉眼可见溃疡、糜烂,大面积覆盖脓苔;镜下肠黏膜大面积受损,形成融合性溃疡,肠壁炎细胞浸润,组织水肿;CD4+、CD8+百分率降低,CD4+/CD8+升高。清胃理肠胶囊治疗后,结肠病理变化基本消失,与模型组比较CD4+、CD8+升高,CD4+/CD8+降低。结论清胃理肠胶囊能够改善溃疡性结肠炎大鼠结肠的病理变化,并调节其免疫功能。 Objective:To observe the effects of Qingweilichang Capsule on pathological change and T lymphocyte subgroups in rats with experimental ulcerative colitis(UC).Methods:The UC models were induced in all the rats except the normal group by the combination of dinitro-chlorobenzene and acetic acid.After gastric perfusion for 20 days,the pathological changes were observed by the naked eye and the microscope.Results:After model establishment,the inflammatory reactions were reduced including the tissue ulceration,the cell infiltration and the tissue edema.The CD4+ percent and the CD8+ percent were decreased.The CD4+/CD8+ was increased.After treatment by the Qingweilichang Capsule,these inflammatory reactions were disappeared.Compared with the model group,the CD4+ percent and the CD8+ percent were increased.The CD4+/CD8+ was fallen.Conclusions:Qingweilichang Capsule can improve the pathological changes and regulate the immunology functions of rats with UC.
出处 《中国中医急症》 2011年第2期262-263,共2页 Journal of Emergency in Traditional Chinese Medicine
基金 陕西省科技攻关项目[2006K13-G4(1)]
关键词 清胃理肠胶囊 溃疡性结肠炎 病理变化 T淋巴细胞亚群 Qingweilichang Capsule Ulcerative colitis Pathological change T lymphocyte subgroup
  • 相关文献

参考文献4

二级参考文献33

  • 1夏冰,张贵水.炎症性肠病的遗传学研究进展[J].国外医学(内科学分册),1996,23(12):513-515. 被引量:2
  • 2Shorter Rg. Idiopathic inflammatory bowel disaese(IBD):A review of immunological mechanisms in ""deveploment in Gastroenterology Volum 3.Inflammatory Bowel Disease"" Rochmile-witz D[M]. Martinus nijhoff Publisher London, 1982.68.
  • 3Brandtzaeg,et al.The human gastrointestinal secretory immune system in health and disease[J]. Scand Gastroentrerol,1985,20 (suppl 114):7.
  • 4Bach MA,et al.the use of monoclonal anti-T cell antibodies to study T cell inbalances in human disease[J]. Clin Exp Immunol,1981,45:449.
  • 5Jewell DP.Immunology Overview[J]. Scand Gastroentrerol,1989,24(suppl 158):35.
  • 6Yan SZ ,et al.Circulating lymghocyte Subpopulations in Crohn's Disease[J]. Gastroenterol,1983,85(6):1313.
  • 7Halstensen T. Epithelial deposition of immunogolbulin Gr and activated complement Ic3b and Terminal complement complex I in ulcerative colitis.Gastroenterology, 1990; 98: 1264
  • 8Freeman H, Roecd B, Devine D,et al. Prospective evaluation of antineutrophil autoantibodise in 500 consecutive patients with inflammatory bowel disease. Can J Gastroenterol, 1997; 11 : 203
  • 9Binion DG, West GA, Ina K, et al. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease.Gastroenterology, 1997 ; 112 : 1895
  • 10Vincenzo CR, Lori K, Yoojin TC, et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immunol, 1995; 154:2434

共引文献19

同被引文献113

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部